跳至主要内容
临床试验/TCTR20220915001
TCTR20220915001招募中3 期

Efficacy of Intraoperative autologous platelet rich plasma injection during carpal tunnel release. A double-blind, randomized controlled trial

Faculty of medicine, Siriraj hospital, Mahidol university0 个研究点目标入组 35 人开始时间: 2022年9月15日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age more than 18 years old
  • 2. Diagnosed with carpal tunnel syndrome using criteria of 2/2 1. Pain or numbness at thumb index middle and radial half of ring finger 2. a positive physical examination of Tinel's sign or Phalen test, or Durkan test
  • 3. Electrodiagnostic confirmed with moderate to severe carpal tunnel syndrome according to American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) guideline
  • 4. Persist symptoms at least 3 months after conservative treatment and requiring carpal tunnel release surgery

排除标准

  • 1. Previous PRP or steroid injection in 6 months
  • 2. History of Inflammatory joint disease e.g. RA, SLE, gouty arthritis
  • 3. History of Peripheral neuropathy, Cervical spondylosis radiculopathy
  • 4. Previous fracture/injury or surgery on the affected hand
  • 5. Cognitive impairment
  • 6. History of Thrombocytopenia or Thrombocytosis

研究者

相似试验